SUN PHARMA GLOBAL FZE has a total of 59 patent applications. It decreased the IP activity by 58.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are HUAIAN ANLAI BIOTECHNOLOGY CO LTD, KAVA PHARMACEUTICALS INC and LUNAN BETTER PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 10 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Israel | 5 | |
#5 | Taiwan | 4 | |
#6 | Norway | 3 | |
#7 | Argentina | 2 | |
#8 | Brazil | 2 | |
#9 | Canada | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Chile | 1 | |
#13 | China | 1 | |
#14 | Hungary | 1 | |
#15 | Japan | 1 | |
#16 | New Zealand | 1 | |
#17 | Singapore | 1 | |
#18 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Packaging and shipping | |
#5 | Computer technology | |
#6 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Milling | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Steroids | |
#7 | Containers for goods storage | |
#8 | Electric digital data processing | |
#9 | Peptides | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Weiss Sidney L | 15 |
#2 | Mitra Ashim K | 9 |
#3 | Nemeth Paul | 9 |
#4 | Mcnally Eugene J | 9 |
#5 | Norret Marck | 9 |
#6 | Bosch H William | 8 |
#7 | Callahan Matt | 6 |
#8 | Bowman Lyle M | 5 |
#9 | Rogue Vincent | 5 |
#10 | Decaudin Celine | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020212874A1 | Methods for treatment of subjects with psoriatic arthritis | |
US2019298738A1 | Methods for treating ocular inflammatory diseases | |
MX2018010395A | Topical cyclosporine-containing formulations and uses thereof. | |
EP3373924A1 | Topical formulations and uses thereof | |
AU2016351588A1 | Topical formulations and uses thereof | |
AU2014280951A1 | Biphenylcarboxamide derivatives as hedgehog pathway modulators | |
AU2014220339A1 | Oral formulation and suspension of an oncology drug | |
AU2013305539A1 | Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions | |
US2008177096A1 | Process for preparation of citalopram and enantiomers | |
US2009326249A1 | Process for preparation of citalopram and enantiomers |